Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-760P** refers to a specific *pseudogene* related to U6 small nuclear RNA (snRNA), named "RNA, U6 small nuclear 760, pseudogene"[1]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations, truncations, or lack of regulatory elements[4]. This pseudogene is not transcribed into a functional RNA molecule and does not play an active biological role in the cell. It is categorized as a non-coding RNA pseudogene and is not considered a protein-coding gene or a target for therapeutic drugs. U6 snRNA, the canonical functional paralog, is essential for pre-mRNA splicing as part of the spliceosomal complex[3][7], but RNU6-760P itself does not contribute to splicing or other known pathways[1][4]. There is no evidence for RNU6-760P involvement in disease, drug response, or as a therapeutic target, and most resources treat its annotation as a processed, non-functional genomic sequence[1][4]. **Notes:** - This gene's classification as a pseudogene means it is *not* a receptor, enzyme, transporter, or therapeutic target. - Its entry in resources like GeneCards and the literature identifies it as biologically inert in terms of coding function and currently not associated with disease or therapy[1][4]. - The name is not misspelled, but requesting drug or disease information about this locus is inappropriate, given its non-functional nature. If you require information on **functional U6 snRNA** (rather than its pseudogenes), it plays an essential role in RNA splicing but is not itself a drug target[3][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 760, pseudogene (RNU6-760P).